0001655774-18-000003.txt : 20180906
0001655774-18-000003.hdr.sgml : 20180906
20180905182036
ACCESSION NUMBER: 0001655774-18-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20180906
DATE AS OF CHANGE: 20180905
EFFECTIVENESS DATE: 20180906
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: OncoResponse Inc
CENTRAL INDEX KEY: 0001655774
IRS NUMBER: 475120470
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-320707
FILM NUMBER: 181056270
BUSINESS ADDRESS:
STREET 1: 909 FANNIN STREET
STREET 2: SUITE 2100
CITY: HOUSTON
STATE: TX
ZIP: 77010
BUSINESS PHONE: (206) 805-1600
MAIL ADDRESS:
STREET 1: 909 FANNIN STREET
STREET 2: SUITE 2100
CITY: HOUSTON
STATE: TX
ZIP: 77010
D
1
primary_doc.xml
X0708
D
LIVE
0001655774
OncoResponse Inc
909 FANNIN STREET
SUITE 2100
HOUSTON
TX
TEXAS
77010
(206) 805-1600
DELAWARE
None
None
Corporation
true
2015
Clifford
Stocks
909 Fannin Street
Suite 2100
Houston
TX
TEXAS
77010
Executive Officer
Director
Roberto
DePonti
412F Route D' Esch L-2086
None
N4
LUXEMBOURG
L-2086
Director
Steven
Gillis
8725 West Higgins Road
Suite 290
Chicago
IL
ILLINOIS
60631
Director
Wende
Hutton
2765 Sand Hill Road
Menlo Park
CA
CALIFORNIA
94025
Director
Nathan
Jorgensen
One Newton Executive Park
2221 Washington Street
Newton
MA
MASSACHUSETTS
02462
Director
John
McKearn
101 S. Hanley Road
Suite 1850
St. Louis
MO
MISSOURI
63105
Director
Andrew
Perlman
744 Montgomery Street
5th Floor
San Francisco
CA
CALIFORNIA
94111
Director
Biotechnology
Decline to Disclose
- 06b
false
2018-08-23
false
true
false
0
39999995
18999999
20999996
false
12
0
0
1200000
true
The amount reflects payments of accrued and unpaid bonuses from periods prior to the offering and anticipated salary to the listed executive officers and potential bonus payments for the following 24-month period.
false
OncoResponse Inc
Clifford J. Stocks
Clifford J. Stocks
Chief Executive Officer
2018-09-01